Recently added articles from Weekly Corporate Growth Report:

Waking the Economic Dragon: China's International Deals

Jun 23, 2008; Dolbeck, Andrew ... While dealmaking may have fallen off in the West, it appears to be on the rise in China. There are big deals going on in China, such as Shenzhen-based China Merchants Bank's recent $4.7 billion takeover of Hong Kong's Wing Lung Bank. But perhaps even more notable is the rise of Chinese ...

Valuations of Recent Initial Public Offerings

Jun 23, 2008; Anonymous ... Britannia Bulk Holdings charters vessels for the transportation of drybulk commodities, including coal, fertilizers, iron ore, and grains. The company's fleet consists of more than 20 vessels, including a dozen drybulk vessels, with a combined overall capacity of approximately 1.1 million ...

Strategy Drift and the Future of Private Equity Dealmaking

Jun 16, 2008; Dolbeck, Andrew ... In 2006, the future of the private equity deal market looked bright. Halfway through 2007, the crash in the subprime mortgage sector sent ripples through the broader credit market, darkening the possibilities for many equity deals already in play. Now, as we approach the third quarter of 2008, ...

It's All Up in the Air: M&A Deals in the Airline Industry

Jun 09, 2008; Dolbeck, Andrew ... Analysts and airline industry executives have stated that merger deals in the airline sector are inevitable. The industry is facing a number of challenges, such as stiff competition and rising operational expenses, particularly the rising cost of jet fuel. Industry consolidation would help ...

Private Equity in the Global Arena

Jun 02, 2008; Dolbeck, Andrew ... Given the difficulties in raising funds and closing deals in the current economy, it is not surprising that private equity groups are exploring international investment opportunities. Foreign private equity firms are also highly active on the international stage. International operations present ...

Bristol-Myers Squibb to Acquire Kosan Biosciences for 10.33 Times Revenue

Jun 02, 2008; Anonymous ... The Deal: Bristol-Myers Squibb Company has entered into a definitive agreement to purchase Kosan Biosciences Inc. for $5.50 per share in a cash tender offer. Under the terms of the agreement, if a majority of Kosan shares are tendered, Bristol-Myers will acquire the remaining untendered shares ...